Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice

Journal of Clinical Investigation

Volumn 111, Issue 3, 2003, Pages 323-332

  Kaifu, Tomonori ^a   Nakahara, Jin ^b   Inui, Masanori ^a   Mishima, Kenichi ^c   Momiyama, Toshihiko ^d   Kaji, Mitsuji ^a   Sugahara, Akiko ^a   Koito, Hisami ^a   Ujike Asai, Azusa ^a   Nakamura, Akira ^a   Kanazawa, Kiyoshi ^e   Tan Takeuchi, Kyoko ^b   Iwasaki, Katsunori ^c   Yokoyama, Wayne M ^f   Kudo, Akira ^e   Fujiwara, Michihiro ^c   Asou, Hiroaki ^b   Takai, Toshiyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; ELECTROPHYSIOLOGY; FRACTURE; GENE DELETION; GENETIC ANALYSIS; IMMUNE SYSTEM; MEMBRANOUS LIPODYSTROPHY; MOUSE; MYELINATION; NERVE DEGENERATION; NONHUMAN; OLIGODENDROGLIA; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SYNAPSE; THALAMUS;

EID: 0037314230     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI16923     Document Type: Article

References (41)

1. Nasu, T., Tsukahara, Y., and Terayama, K. 1973. A lipid metabolic disease-"membranous lipodystrophy"-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol. Jpn. 23:539-558.
2. Hakola, H.P.A. 1972. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr. Scand. 232(Suppl.):1-173.
3. Verloes, A., et al. 1997. Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy and presenile dementia. J. Med. Genet. 34:753-757.
4. Tanaka, J. 2000. Nasu-Hakola disease: a review of its leukoencephalopathic and membranolipodystrophic features. Neuropathology. 20:S25-S29.
5. Paloneva, J., et al. 2001. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology. 56:1552-1558.
6. Paloneva, J., et al. 2000. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25:357-361.
7. Olcese, L., et al. 1997. Killer-cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by human killer cells. J. Immunol. 158:5083-5086.
8. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C., and Phillips, J.H. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:703-707.
9. Daws, M.R., Lanier, L.L., Seaman, W.E., and Ryan, J.C. 2001. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J. Immunol. 31:783-791.
10. Bouchon, A., Hernández-Munain, C., Cella, M., and Colonna, M. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med 194:1111-1122.
11. Bakker, A.B.H., et al. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity. 13:345-353.
12. Tornasello, E., et al. 2000. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity. 13:355-364.
13. Aoki, N., et al. 2000. The role of the DAP12 signal in mouse myeloid differentiation. J. Immunol. 165:3790-3796.
14. Paloneva, J., et al. 2002. Mutations in two genes encoding different sub-units of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71:656-662.
15. Takai, T., Li, M., Sylvestre, D., Clynes, R., and Ravetch, J.V. 1994. FcR γ chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529.
16. Seiwa, C., Sugiyama, I., Yagi, T., Iguchi, T., and Asou, H. 2000. Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system. Neurosci. Res. 37:21-31.
17. Knapp, P.E., Skoff, R.P., and Sprinkle, T. J. 1988. Differential expression of galactocerebroside, myelin basic protein, and 2′,3′-cyclic nucleotide 3′-phosphohydrolase during development of oligodendrocytes in vitro. J. Neurosci. Res. 21:249-259.
18. Bottenstein, J.E. 1986. Growth requirement in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. Proc. Natl. Acad. Sci USA. 83:1955-1959.
19. 125I]insulin to specific receptors and stimulation of nucleotide incorporation in cells cultured from rat brain. Brain Res. 200:389-400.
20. Matsuda, Y., Koito, H., and Yamamoto, H. 1997. Indication of myelin-associated glycoprotein expression through neuron-oligodendrocyte contact. Dev. Brain Res. 100:110-116.
21. 2+ channels to reduce GABA release onto rat striatal cholinergic interneuzrones. J. Physiol. (Lond.) 533:479-492.
22. Chang, C., et al. 1999. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J. Immunol. 163:4651-4654.
23. Wu, J., et al. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:730-732.
24. Yoshida, H., et al. 1990.The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:442-444.
25. McLean, W., and Olsen, B.R. 2001. Mouse models of abnormal skeletal development and homeostasis. Trends Genet. 17:S38-S43.
26. Kodama, H., Nose, M., Niida, S., and Yamasaki, A. 1991. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J. Exp. Med. 173:1291-1294.
27. Kong, Y.Y., et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:315-323.
28. Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., and Kudo, A. 2000. Tumor necrosis Factor-α induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275:4858-4864.
29. Griffiths, I., et al. 1998. Axonal swelling and degeneration in mice lacking the major proteolipid of myelin. Science. 280:1610-1613.
30. Duponey, P., et al. 1979. Immunochemical studies of myelin basic protein in shiverer mouse devoid of major dense line of myelin. Neurosci. Lett. 12:113-118.
31. Kobayashi, K., et al. 2000. Hypothalamic haemorrhage and thalamus degeneration in a case of Nasu-Hakola disease with hallucinatory symptoms and central hypothermia. Neuropathol. Appl. Neurobiol. 26:98-101.
32. A receptor α subunits expression with the properties of IPSCs in the developing thalamus. J. Neurosci. 20:2202-2208.
33. A receptor/chloride channel complex in anesthesia. Anesthesiology. 78:757-776.
34. Franks, N.P., and Lieb, W.R. 1994. Molecular and cellular mechanisms of general anesthesia. Nature. 367:607-614.
35. Kim, U., Sanchez-Vives, M.V., and McCormick, D.A. 1997. Functional dynamics of GABAergic inhibition in the thalamus. Science. 278:130-134.
36. Braff, D.L., et al. 2001. Impact of prepulse characteristics on the detection of sensorimoror gating deficits in schizophrenia. Schizopbr. Res. 49:171-178.
37. Romanski, L.M., and LeDoux, J.E. 1992. Equipotentiality of thalamoamygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning. J. Neurosci. 12:4501-4509.
38. Wu, M.F., Mallick, B.N., and Siegel, J.M. 1989. Lateral geniculate spikes, muscle atonia and startle response elicited by auditory stimuli as a function of stimulus parameters and arousal state. Brain Res. 499:7-17.
39. Kodsl, M.H., and Swerdlow, N.R. 1997. Regulation of prepulse inhibition by ventral pallidal projections. Brain Res. Bull. 43:219-228.
40. Andreasen, N.C., et al. 1994. Thalamic abnormalities in schizophrenia visualized thorough magnetic resonance image averaging. Science. 266:294-298.
41. Hakak, Y., et al. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA. 98:4746-4751.